Pei-chang H. Lee

Yuanshan Branch
Yilan, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 105 publications

Atezolizumab plus Bevacizumab versus Lenvatinib as First-Line Treatment for Unresectable Hepatocellular Carcinoma Stratified by the CRAFITY Score: An International Multicenter Study.

Atezolizumab plus Bevacizumab versus Lenvatinib as First-Line Treatment for Unresectable Hepatocellular Carcinoma Stratified by the CRAFITY Score: An International Multicenter Study.

Journal: Liver cancer

Published: February 06, 2026

Machine learning-based decision-tree model for patients with single-large hepatocellular carcinoma.

Machine learning-based decision-tree model for patients with single-large hepatocellular carcinoma.

Journal: Journal of the Chinese Medical Association : JCMA

Published: December 08, 2025

Determinants of long-term survival from atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma.

Determinants of long-term survival from atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: November 28, 2025

Addition of Intra-Arterial Therapy to Immunotherapy Improves Outcomes in Unresectable Hepatocellular Carcinoma: Taiwan Multicenter Cohort Study.

Addition of Intra-Arterial Therapy to Immunotherapy Improves Outcomes in Unresectable Hepatocellular Carcinoma: Taiwan Multicenter Cohort Study.

Journal: Liver cancer

Published: November 13, 2025

Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma patients with normal serum alpha-fetoprotein levels.

Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma patients with normal serum alpha-fetoprotein levels.

Journal: Journal of the Chinese Medical Association : JCMA

Published: October 22, 2025

Continuous Versus Bolus Terlipressin for Acute Oesophageal Variceal Bleeding and Hepatorenal Syndrome in Cirrhosis: Meta-Analysis.

Continuous Versus Bolus Terlipressin for Acute Oesophageal Variceal Bleeding and Hepatorenal Syndrome in Cirrhosis: Meta-Analysis.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: October 20, 2025

NALIRIFOX versus liposomal irinotecan plus fluorouracil/leucovorin as the second-line chemotherapy in gemcitabine refractory pancreatic adenocarcinoma: a real-world study.

NALIRIFOX versus liposomal irinotecan plus fluorouracil/leucovorin as the second-line chemotherapy in gemcitabine refractory pancreatic adenocarcinoma: a real-world study.

Journal: Therapeutic advances in medical oncology

Published: October 04, 2025

A myeloid immunosuppressive phenotype defines primary refractoriness to atezolizumab plus bevacizumab in hepatocellular carcinoma.

A myeloid immunosuppressive phenotype defines primary refractoriness to atezolizumab plus bevacizumab in hepatocellular carcinoma.

Journal: Journal of hepatology

Published: September 04, 2025

Patterns and Prognostic Stratification of Recurrence after Thermal Ablation in Patients with Hepatocellular Carcinoma.

Patterns and Prognostic Stratification of Recurrence after Thermal Ablation in Patients with Hepatocellular Carcinoma.

Journal: Liver cancer

Published: August 13, 2025

Reply: Is fecal acetate a viable pan-etiological predictor of outcomes in HCC immunotherapy?

Reply: Is fecal acetate a viable pan-etiological predictor of outcomes in HCC immunotherapy?

Journal: Hepatology (Baltimore, Md.)

Published: July 23, 2025

Effects of Auricular Acupressure on Fatigue, Sleep Quality, Physical Activity, and Quality of Life in Pancreatic Cancer Patients Undergoing Chemotherapy: A Randomized Controlled Trial: Erratum.

Effects of Auricular Acupressure on Fatigue, Sleep Quality, Physical Activity, and Quality of Life in Pancreatic Cancer Patients Undergoing Chemotherapy: A Randomized Controlled Trial: Erratum.

Journal: Cancer nursing

Published: July 07, 2025

Integration of local and systemic immunotherapy: setting new standards in liver-confined hepatocellular carcinoma.

Integration of local and systemic immunotherapy: setting new standards in liver-confined hepatocellular carcinoma.

Journal: Translational gastroenterology and hepatology

Published: June 28, 2025

Showing 1-12 of 105

Last Updated: 09/26/2026